To help achieve its goals, the NAVP convened a workgroup of vaccine and policy experts to provide strategic recommendations and direction that focus on improving adult immunization rates and creating sustainable change.   

douglasR. Gordon Douglas, MD
R. Gordon Douglas is currently Professor Emeritus of Medicine at Weill Cornell Medical College; Chairman of Aeras (formerly Aeras Global TB Vaccine Foundation), a non-profit biotech company; Director of two biotech companies: Vical, Inc. (Chairman), and Novadigm (Chairman).  Dr. Douglas served as a consultant to the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), from 1999-2011. He retired from Merck & Co. in 1999 after serving as President, Merck Vaccine Division, and a member of its Management Committee for 9 years.  Dr. Douglas is a graduate of Princeton University (1955) and Cornell University Medical College (1959). After internal medicine training at the New York Hospital and Johns Hopkins Hospital, and infectious disease training at NIAID, he served successively as Head of the Infectious Disease Unit, University of Rochester, (1970-1982) and Chairman, Department of Medicine and Physician-in-Chief at New York Hospital Cornell Medical Center (1982-1990) before joining Merck. He is author of over 190 original scientific publications dealing with viral pathogenesis, vaccines, and anti-virals, and was co-editor (with Gerald Mandell and John Bennett) of Principles and Practices of Infectious Diseases, the standard reference in the field. He is recipient of the R.R. Hawkins Award (Association of American Publishers, 1980), the H. Feldman Award (Infectious Disease Society of America, 1992), and the Maxwell Finland Award (National Foundation for Infectious Diseases, 2000). He is a member of the Institute of Medicine, the Association of American Physicians, the American Society of Clinical Investigation, and the American Clinical and Climatologic Association. He recently retired as trustee of McCarter Theater, the National Foundation for Infectious Diseases, and the Lyme Academy College of Fine Arts.  He served as President of the Class of 1955 at Princeton University from 2005 until 2010.


cantuMichelle Cantu, MPH
Michelle Cantu is the Director for Infectious Disease and Immunization at the National Association of County and City Health Officials (NACCHO), a nonprofit representing nearly 3,000 local health departments nationwide. At NACCHO, Michelle leads the Immunization Program to engage local health departments to increase their capacity in prevention and control of vaccine preventable diseases. She oversees the management of the immunization advisory workgroup, national partnerships among multidisciplinary groups addressing VPDs, and evaluation to further enhance programmatic strategies, policies, and activities. Michelle has over 12 years of leadership experience in public health with a focus on infectious disease prevention. Prior to her role at NACCHO, Michelle was the Director of Community-Based STD Prevention Initiatives at Essential Access Health (formerly California Family Health Council) in Los Angeles, California. In that role, she worked with a diverse group of health centers on quality improvement programs related to reproductive health delivery, services, and data. She obtained her Master of Public Health (MPH) from the Johns Hopkins Bloomberg School of Public Health with a focus in infectious diseases and epidemiology and holds a Bachelor of Arts from the University of Texas at Austin.


dcasanovaDanielle Casanova, MBA
Danielle Casanova is responsible for establishing the AMGA population health initiatives’ overall vision, and she provides oversight on all collaborative and acclaim award activities. She leads strategic direction and planning of current and future quality collaboratives and the acclaim award program. She has spent 17 years in total, working for healthcare associations developing, training, and implementing national healthcare programs for the American Diabetes Association and national population health and quality programs for AMGA. Ms. Casanova received her undergraduate degree in Biology with a concentration in PreMedicine and has a master’s degree in Business Administration with a concentration in Healthcare Management.  


gravensteinStefan Gravenstein, MD, MPH
Stefan Gravenstein is Professor of Medicine at Case Western Reserve University School of Medicine in Cleveland, Ohio. He serves as Interim Chief of the Division of Geriatrics and Palliative Care at Case Western Reserve University and as Director of the Center for Geriatrics and Palliative Care at University Hospitals–Case Medical Center.  Dr. Gravenstein is also Adjunct Professor of Medicine at the Alpert Medical School and School of Public Health at Brown University in Providence, Rhode Island. He received his medical degree from The Ohio State University in Columbus.  Dr. Gravenstein completed his residency at University of Wisconsin Hospitals and Clinics followed by a geriatrics fellowship and postdoctoral training at William S. Middleton Veterans Hospital, both in Madison, Wisconsin. He received his master of public health from Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia. Dr. Gravenstein has a long-standing interest in immunity, inflammation, and aging especially in the context of immune senescence, vaccination, influenza, and nursing home care. He also has a specific interest in quality improvement in health care, the culture of care, and how to improve care across care transitions. He has investigated these topics with uninterrupted competitive funding since 1989.  Dr. Gravenstein has authored more than 120 peer-reviewed articles, 20 books, and chapters. In addition, he currently serves as clinical section editor for Gerontology and reviewer for several journals.  Dr. Gravenstein is a workgroup member and Project Director of the National Adult Vaccination Program. He is a member of many professional societies, including the American College of Physicians, American Geriatrics Society, The Gerontological Society of America, American Medical Directors Association, and American Medical Association. He also is a member of the Infectious Diseases Society of America’s influenza guideline panel.


resnick

Barbara Resnick, PhD, RN, CRNP    
Barbara Resnick received a bachelor of science in nursing from the University of Connecticut, a master of science in nursing from the University of Pennsylvania, and a doctoral degree in nursing from the University of Maryland.

Dr. Resnick’s research focus has been on motivation of older adults, particularly with regard to performance of functional activities and engaging in regular exercise.  Included among her research activities have been several federally funded projects focused on older adults such as Testing the Reliability and Validity of the Exercise Plus Program Post Hip Fracture (NIA RO1 AG17082-01) and Testing the Effectiveness of the Res-Care Intervention (AHRQ R01 HS/MH 13372-010). In addition, Dr. Resnick has numerous projects focused on testing exercise interventions across a variety of clinical areas: community dwelling older adults in a continuing care retirement community and minority older adults in senior centers.  Similarly, Dr. Resnick is the primary investigator on several measurement studies related to physical activity in older adults. She has authored over 100 manuscripts, numerous book chapters on both clinical and research topics relevant to the care of older adults, and she recently authored a book on restorative care nursing.  Dr. Resnick is a fellow in the Academy of Nursing and the American Academy of Nurse Practitioners, received the 2003 Distinguished Faculty Research Award from the University of Maryland, and numerous awards for both her clinical work as well as her research.

 

schaffnerWilliam Schaffner, MD    
William Schaffner is Chairman of the Department of Preventive Medicine as well as Professor of Infectious Diseases in the Department of Medicine at the Vanderbilt University School of Medicine.  His primary interests are infectious diseases and their prevention.  Dr. Schaffner has worked extensively on the effective use of vaccines in both pediatric and adult populations.  He is a strong proponent of collaboration between academic medical centers and public health institutions.

Dr. Schaffner is a liaison representative to the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) and is a member of the Immunization Technical Advisory Committee of the American College of Physicians.  He is a former member of the National Vaccine Advisory Committee (NVAC), Past President of the Society for Healthcare Epidemiology of America, and a former Councilor and Secretary of the Board of Directors of the Infectious Diseases Society of America.  Currently, he is President of the National Foundation for Infectious Diseases.  Dr. Schaffner is a consultant in public health policy and communicable disease control for numerous national and local institutions including the CDC, the World Health Organization, and the Tennessee Department of Health.  Dr. Schaffner is a member of numerous professional societies and has written over 400 scientific articles and textbook chapters.  He often is called upon to communicate about public health issues in the print media and television.

After graduation from Yale in 1957, Dr. Schaffner attended the University of Freiburg, Germany, as a Fulbright Scholar.  In 1962, he graduated from Cornell University Medical College and completed an internship, residency training, and a fellowship in Infectious Diseases at Vanderbilt University Medical Center.  He was commissioned in the U.S. Public Health Service as an Epidemic Intelligence Service Officer with the CDC  in Atlanta for 2 years (1966-1968), returning to Vanderbilt after that tour of duty.